Masimo Operating Expenses 2010-2025 | MASI
Masimo annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Masimo operating expenses for the quarter ending June 30, 2025 were $0.306B, a 1.46% increase year-over-year.
- Masimo operating expenses for the twelve months ending June 30, 2025 were $2.373B, a 53.38% increase year-over-year.
- Masimo annual operating expenses for 2024 were $2.361B, a 23.51% increase from 2023.
- Masimo annual operating expenses for 2023 were $1.912B, a 4.7% increase from 2022.
- Masimo annual operating expenses for 2022 were $1.826B, a 89.52% increase from 2021.
| Masimo Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $2,361 |
| 2023 | $1,912 |
| 2022 | $1,826 |
| 2021 | $963 |
| 2020 | $888 |
| 2019 | $717 |
| 2018 | $650 |
| 2017 | $606 |
| 2016 | $277 |
| 2015 | $510 |
| 2014 | $483 |
| 2013 | $468 |
| 2012 | $408 |
| 2011 | $352 |
| 2010 | $299 |
| 2009 | $267 |
| Masimo Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $306 |
| 2025-03-31 | $294 |
| 2024-12-31 | $1,298 |
| 2024-09-30 | $475 |
| 2024-06-30 | $302 |
| 2024-03-31 | $287 |
| 2023-12-31 | $505 |
| 2023-09-30 | $454 |
| 2023-06-30 | $426 |
| 2023-03-31 | $527 |
| 2022-12-31 | $544 |
| 2022-09-30 | $495 |
| 2022-06-30 | $543 |
| 2022-03-31 | $245 |
| 2021-12-31 | $250 |
| 2021-09-30 | $240 |
| 2021-06-30 | $240 |
| 2021-03-31 | $233 |
| 2020-12-31 | $230 |
| 2020-09-30 | $218 |
| 2020-06-30 | $239 |
| 2020-03-31 | $201 |
| 2019-12-31 | $186 |
| 2019-09-30 | $177 |
| 2019-06-30 | $178 |
| 2019-03-31 | $176 |
| 2018-12-31 | $169 |
| 2018-09-30 | $162 |
| 2018-06-30 | $160 |
| 2018-03-31 | $159 |
| 2017-12-31 | $163 |
| 2017-09-30 | $150 |
| 2017-06-30 | $148 |
| 2017-03-31 | $144 |
| 2016-12-31 | $-124 |
| 2016-09-30 | $131 |
| 2016-06-30 | $136 |
| 2016-03-31 | $134 |
| 2015-12-31 | $130 |
| 2015-09-30 | $124 |
| 2015-06-30 | $128 |
| 2015-03-31 | $127 |
| 2014-12-31 | $129 |
| 2014-09-30 | $122 |
| 2014-06-30 | $123 |
| 2014-03-31 | $110 |
| 2013-12-31 | $130 |
| 2013-09-30 | $111 |
| 2013-06-30 | $114 |
| 2013-03-31 | $113 |
| 2012-12-31 | $110 |
| 2012-09-30 | $101 |
| 2012-06-30 | $100 |
| 2012-03-31 | $97 |
| 2011-12-31 | $92 |
| 2011-09-30 | $85 |
| 2011-06-30 | $87 |
| 2011-03-31 | $88 |
| 2010-12-31 | $84 |
| 2010-09-30 | $78 |
| 2010-06-30 | $79 |
| 2010-03-31 | $58 |
| 2009-12-31 | $71 |
| 2009-09-30 | $67 |
| 2009-06-30 | $64 |
| 2009-03-31 | $65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.912B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| Alcon (ALC) | Switzerland | $39.973B | 26.83 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| STERIS (STE) | Ireland | $24.578B | 26.16 |
| Waters (WAT) | United States | $17.663B | 24.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Alphatec Holdings (ATEC) | United States | $2.351B | 0.00 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| Integra LifeSciences Holdings (IART) | United States | $1.111B | 6.37 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.665B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 9.31 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |